Inventor
DEVASTHALE PRATIK
US34 patents
⚠️ This page may combine multiple inventors who share the name “DEVASTHALE PRATIK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
28 patentsUS6727271B2Apr 27, 2004
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO92 citations98
US6673815B2Jan 6, 2004
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO98 citations98
US6414002B1Jul 2, 2002
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO204 citations98
US6653314B2Nov 25, 2003
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO67 citations96
US8791091B2Jul 29, 2014
Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO18 citations92
US7521557B2Apr 21, 2009
Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
BRISTOL MYERS SQUIBB CO11 citations84
US9901572B2Feb 27, 2018
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO6 citations83
US9663466B2May 30, 2017
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO8 citations83
US9187424B1Nov 17, 2015
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO10 citations83
US7279485B2Oct 9, 2007
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO11 citations83
US7053106B2May 30, 2006
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO10 citations82
US7084162B2Aug 1, 2006
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO4 citations73
US10695328B2Jun 30, 2020
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US10369140B2Aug 6, 2019
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US10968219B2Apr 6, 2021
3-substituted propionic acids as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO2 citations68
US7989433B2Aug 2, 2011
Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO4 citations63
US10966967B2Apr 6, 2021
Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US7951793B2May 31, 2011
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO2 citations62
US7557143B2Jul 7, 2009
Thyroid receptor ligands
BRISTOL MYERS SQUIBB CO4 citations60
US11884661B2Jan 30, 2024
3-substituted propionic acids as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US11639353B2May 2, 2023
Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US11014922B2May 25, 2021
Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US12269819B2Apr 8, 2025
Small molecule inhibitors of Galectin-3
BRISTOL MYERS SQUIBB CO0 citations51
US8754211B2Jun 17, 2014
Azolotriazinone melanin concentrating hormone receptor-1 antagonists
BRISTOL MYERS SQUIBB CO0 citations49
US12286424B2Apr 29, 2025
Small molecule inhibitors of galectin-3
BRISTOL MYERS SQUIBB CO0 citations47
US10851098B2Dec 1, 2020
Azole amides and amines as alpha v integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations42
US7579479B2Aug 25, 2009
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO0 citations41
US9974778B2May 22, 2018
Substituted pyridinones as MGAT2 inhibitors
BRISTOL MYERS SQUIBB CO0 citations35